These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4425889)

  • 21. Abnormal drug metabolism after barbiturate and paracetamol overdose.
    Forrest JA; Roscoe P; Prescott LF; Stevenson IH
    Br Med J; 1974 Nov; 4(5943):499-502. PubMed ID: 4434117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipyrine kinetics following tetanus vaccination.
    Descotes J; Simonet R; Evreux JC
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):625-6. PubMed ID: 3793297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the regulation of antipyrine and oxazepam metabolism in man.
    Kellermann GH; Luyten-Kellermann M
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
    Adamska-Dyniewska H; Dziekański S; Pruszczyński J
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of antipyrine, acetaminophen and lidocaine in fed and fasted horses.
    Engelking LR; Blyden GT; Lofstedt J; Greenblatt DJ
    J Vet Pharmacol Ther; 1987 Mar; 10(1):73-82. PubMed ID: 3586126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disappearance of phenazone from plasma in patients with obstructive jaundice.
    Elfström J; Lindgren S
    Eur J Clin Pharmacol; 1974 Oct; 7(6):467-71. PubMed ID: 4439871
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of acute and chronic exercise on hepatic drug metabolism.
    Døssing M
    Clin Pharmacokinet; 1985; 10(5):426-31. PubMed ID: 3899456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary antipyrine half-life: a useful measure of hepatic drug metabolism.
    Brooks PM; Bell MA; Burns H
    Br J Clin Pharmacol; 1976 Oct; 3(5):945-6. PubMed ID: 973995
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatic elimination of indocyanine green and antipyrine in patients with chronic liver disease].
    Kuntz HD; Meessen D; May B
    Med Welt; 1982 Jun; 33(25):909-10. PubMed ID: 7109938
    [No Abstract]   [Full Text] [Related]  

  • 30. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.
    Thomson PD; Melmon KL; Richardson JA; Cohn K; Steinbrunn W; Cudihee R; Rowland M
    Ann Intern Med; 1973 Apr; 78(4):499-508. PubMed ID: 4694036
    [No Abstract]   [Full Text] [Related]  

  • 31. Impairment of hepatic drug metabolism in patients with Budd-Chiari syndrome.
    Narang AP; Datta DV; Mathur VS
    Indian J Med Res; 1982 Apr; 75():567-73. PubMed ID: 7106896
    [No Abstract]   [Full Text] [Related]  

  • 32. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipyrine metabolism and bronchogenic carcinoma.
    Ambre J; Graeff D; Bures F; Haupt D; Deason K
    J Med; 1977; 8(1):57-70. PubMed ID: 267157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antipyrine elimination in acute toxic hepatitis in rats].
    Mach T; Barylak H
    Folia Med Cracov; 1978; 20(3):383-8. PubMed ID: 393583
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical significance of antipyrine metabolism in patients with various liver diseases (author's transl)].
    Takashi M; Musha H; Tsuchiya S; Gotoh N; Takayasu K; Suzuki N; Kotoda K; Okuda K
    Nihon Shokakibyo Gakkai Zasshi; 1981 Feb; 78(2):182-9. PubMed ID: 7241823
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of thyroid status on plasma half-life of antipyrine in man.
    Eichelbaum M; Bodem G; Gugler R; Schneider-Deters D; Dengler HJ
    N Engl J Med; 1974 May; 290(19):1040-2. PubMed ID: 4821905
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antipyrine test in evaluation of the functional state of the liver in the postoperative period].
    Nadzhimutdinov KN; Krakovskiĭ ME; Ashirmetov AKh; Komarin AS; Kaiumov TKh
    Khirurgiia (Mosk); 1986 Feb; (2):21-3. PubMed ID: 3959450
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired oxidation of antipyrine in stagnant loop rats.
    Aarbakke J
    Scand J Gastroenterol; 1977; 12(8):929-35. PubMed ID: 605352
    [No Abstract]   [Full Text] [Related]  

  • 40. Monthly variations in the pharmacokinetics of antipyrine in calves.
    Janus K; Baranow-Baranowski S; Jakubowska D; Jankowiak D; Skrzypczak WF
    Arch Vet Pol; 1992; 32(3-4):113-8. PubMed ID: 1339566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.